Delphine Labolle is a clinical research professional with 5 years' experience in clinical operations for phase I, IIa and III studies, mainly in Eastern and Western Europe. Her areas of expertise span rare diseases, Crohn disease, renal transplantation, multiple sclerosis and type 1 diabetes. After studying for a master's degree in drug development in France, Delphine worked as a Clinical Trial Coordinator for Merck Serono International SA, as a Clinical Trial Assistant, a Clinical Research Associate and more recently before joining EspeRare, as a Clinical Scientist for a biotech company based in Geneva. In this position, Delphine was responsible for ensuring the delivery of clinical studies in line with the global strategy for the development program of a monoclonal antibody. At EspeRare, Delphine is responsible for the on-going phase Ib clinical trial of Rimeporide in Duchenne Muscular Dystrophy.
Clinical Project Manager
As a private non-for-profit organisation, we strive to uncover the potential of existing molecules to address severe therapeutic unmet needs in rare diseases, thus giving better chances to existing drugs to reach these underserved patients.